PP
BSX icon

PDS Planning’s Boston Scientific BSX Stock Holding History

PDS Planning’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Buy
8,335
+46
+0.6% +$2.5K 0.02% 378
2026
Q1 		$520K Sell
8,289
-301
-4% -$24.1K 0.03% 262
2025
Q4 		$819K Sell
8,590
-133
-2% -$13K 0.05% 170
2025
Q3 		$852K Sell
8,723
-208
-2% -$21.5K 0.06% 153
2025
Q2 		$959K Buy
8,931
+918
+11% +$92.9K 0.07% 135
2025
Q1 		$808K Buy
8,013
+539
+7% +$54.3K 0.07% 132
2024
Q4 		$668K Buy
7,474
+113
+2% +$9.95K 0.06% 146
2024
Q3 		$617K Buy
7,361
+192
+3% +$15.1K 0.06% 157
2024
Q2 		$552K Buy
7,169
+1,690
+31% +$124K 0.06% 156
2024
Q1 		$375K Buy
5,479
+515
+10% +$33.1K 0.04% 208
2023
Q4 		$287K Buy
4,964
+496
+11% +$26.5K 0.03% 241
2023
Q3 		$236K Buy
4,468
+379
+9% +$19.9K 0.03% 258
2023
Q2 		$221K Buy
+4,089
New +$214K 0.03% 273

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PDS Planning's BSX Position: Q2 2026 in Review

PDS Planning increased its Boston Scientific (BSX) stake by 0.55% in Q2 2026, buying an estimated $2.5K and bringing the position to 8,335 shares worth $356K. The position accounts for 0.02% of the portfolio, ranked #378.

PDS Planning first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $959K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • PDS Planning held 8,335 shares of Boston Scientific worth $356K as of Q2 2026.
  • PDS Planning bought 46 Boston Scientific shares in Q2 2026, an estimated $2.5K.
  • Boston Scientific made up 0.02% of PDS Planning's portfolio in Q2 2026, its #378 holding.
  • PDS Planning first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
  • PDS Planning's Boston Scientific position peaked at $959K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on PDS Planning's 13F filing for Q2 2026, filed 5 Aug 2026.